Citation Tools

Original research
LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

Download to a citation manager

Cite this article as:
Brown LC, Tucker MD, Sedhom R, et al
LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types